Clinical Trial Update: Evaluation of the Efficacy and Safety of DM05 Versus Optive™ on the Treatment of Moderate to Severe Ocular Dryness [NA]

View source ↗

Summary

The trial compared DM05 to Optive for treating moderate to severe dry eye. It has completed and evaluated efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• DM05
• Optive

Snippet

Sponsor: Horus Pharma | Conditions: Dry Eye | NA | Status: COMPLETED